Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study on Clinical Efficacy and Safety of Levocetirizine 5 mg Oral Capsules Once Daily in the Morning vs. Desloratadine 5 mg Oral Capsules Once Daily in the Morning in Patients Suffering From Chronic Idiopathic Urticaria (CIU)

NCT00264303 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00264303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00264303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study on Clinical Efficacy and Safety of Levocetirizine 5 mg Oral Capsules Once Daily in the Morning vs. Desloratadine 5 mg Oral Capsules Once Daily in the Morning in Patients Suffering From Chronic Idiopathic Urticaria (CIU)
Lead sponsor
UCB Pharma
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
January 31, 2007
Enrollment
886 (actual)
Sites
80

Conditions

As the registry lists them; a condition with its own page is linked.

chronic idiopathic urticaria